|

Cisplatin or Carboplatin Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Shanghai Junshi Bioscience Co., Ltd.1
  • Shanghai JMT-Bio Inc.1

Indications

  • Lung Cancer2
  • Cancer2
  • Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor1
  • Non Small Cell Lung Cancer1

Other2 trials

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Phase 1
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.